Source: BusinessWire
epiq Animal Health and Vetirus Animal Health have entered into a distribution and strategic partnership designed to expand access to regenerative medicine solutions for Veterinary professionals across the United States. Under the agreement, epiq Animal Health will serve as the exclusive U.S. distributor of Rebound™ High Performance PRP, Vetirus’ flagship platelet-rich plasma (PRP) product. Rebound PRP is an FDA-registered, university-validated regenerative therapy that uses concentrated autologous platelet-rich plasma to promote healing, reduce inflammation, and support tissue regeneration in animals with orthopedic conditions.
Vetirus CEO Robert N. Jordan said the partnership combines Vetirus’ innovative regenerative technology with epiq’s extensive distribution network, technical expertise, and commitment to advancing Veterinary medicine. In addition to managing distribution and supply chain solutions, both companies will collaborate on education and training initiatives to help veterinarians confidently integrate regenerative therapies into clinical practice. The partnership aims to improve product availability, provide clinical support, and accelerate adoption of regenerative medicine solutions among companion animal and equine practitioners throughout the Veterinary profession.